文献速递炎症性肠病

早期启动抗TNF治疗可降低克罗恩病远期医疗资源利用但溃疡性结肠炎无此效果

Earlier Anti-TNF Initiation Leads to Long-term Lower Health Care Utilization in Crohn's Disease but Not in Ulcerative Colitis.
PubMed 文献 · Clin Gastroenterol Hepatol · 2022-03-03

该研究利用加拿大曼尼托巴省2001至2018年卫生行政数据,纳入742例克罗恩病和318例溃疡性结肠炎患者,比较诊断后2年内与超过2年启动抗TNF治疗者的医疗资源利用。结果显示早期启动抗TNF的克罗恩病患者5年内IBD相关和总体住院更少,排除启动后第一年分析时切除手术发生率也更低;溃疡性结肠炎患者中启动时机对住院和手术率无影响。

要点

  • 克罗恩病患者诊断后2年内启动抗TNF,5年内IBD相关和总体住院更少。
  • 克罗恩病早期启动者排除第一年分析时切除手术发生率更低。
  • 溃疡性结肠炎患者抗TNF启动时机对住院和手术率无影响。

核心结论

  • 早期给予抗TNF治疗与克罗恩病下游医疗资源利用减少相关,但在溃疡性结肠炎中未见这些影响。

研究设计与样本

  • 使用加拿大曼尼托巴省2001至2018年卫生行政数据,纳入新诊断炎症性肠病并接受抗TNF治疗且启动后随访至少1年的患者。
  • 比较诊断后2年内启动抗TNF者与超过2年启动者的住院、手术和门诊就诊率,随访至启动后5年。
  • 采用逆概率治疗加权调整两组基线风险差异。

主要发现

  • 742例克罗恩病患者中,早期启动抗TNF者在治疗开始后5年内IBD相关和总体住院更少。
  • 克罗恩病早期启动抗TNF者若排除启动后第一年分析,切除手术发生率也更低。
  • 318例溃疡性结肠炎患者中,抗TNF启动时机对住院率和手术率无影响。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND & AIMS: The timing of initiating biologic therapy in persons with Crohn's disease (CD) and ulcerative colitis (UC) is an area of ongoing controversy. In particular, there is concern that delaying the initiation of biologic therapy may lead to more treatment-resistant disease, which can result in more complications and hospitalizations. METHODS: We used health administrative data from Manitoba, Canada to identify all persons with a new diagnosis of inflammatory bowel disease (IBD) between 2001 and 2018 who received tumor necrosis factor antagonists (anti-TNF) therapy and had at least 1 year of post anti-TNF initiation follow-up. We measured the rates of hospitalization, surgery, and outpatient visits, prior to and for up to 5 years following anti-TNF initiation. We compared the rates of these health care utilization outcomes between persons receiving anti-TNFs within 2 years following diagnosis and those receiving anti-TNFs more than 2 years following IBD diagnosis. We used inverse probability treatment weighting to adjust for baseline differences in risk between the 2 groups. RESULTS: Among 742 persons with CD, early anti-TNF initiators had fewer IBD-specific and overall hospitalizations over the 5 years following the start of therapy. Incidence of resective surgery was also lower in earlier anti-TNF initiators with CD if the first year following initiation was excluded from the analysis. In 318 cases of UC, there was no impact of the timing of anti-TNF therapy on the rates of hospitalization and surgery. CONCLUSIONS: Earlier administration of anti-TNF therapy is associated with reduced downstream health care resource utilization in CD, though these impacts are not evident in UC.

来源:Clin Gastroenterol Hepatol,查看原文。版权归原作者所有。

引用

  1. Targownik LE, Bernstein CN, Benchimol EI, et al. Earlier Anti-TNF Initiation Leads to Long-term Lower Health Care Utilization in Crohn's Disease but Not in Ulcerative Colitis. Clin Gastroenterol Hepatol. 2022. PMID: 35247552. doi:10.1016/j.cgh.2022.02.021

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。